The utility of pharmacogenetic testing to support the treatment of bipolar disorder

BACKGROUND: Bipolar disorder (BD) is a frequent cause of disability, health care costs, and risk of suicide. Pharmacogenetic tests (PGTs) could help clinicians to identify those patients predisposed to the occurrence of adverse events (AEs) improving the understanding of the correlation between gene...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmgenomics Pers Med
Hauptverfasser: Ielmini, Marta, Poloni, Nicola, Caselli, Ivano, Espadaler, Jordi, Tuson, Miquel, Grecchi, Alessandro, Callegari, Camilla
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove Medical Press 2018
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5860421/
https://ncbi.nlm.nih.gov/pubmed/29588611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S160967
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge